Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | BTN3A1 | O00481 | 3/20 | 0.33 |
| ▸ | LAP3 | P28838 | 3/20 | 0.33 |
| ▸ | MVD | P53602 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 3/20 | 0.30 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL299589 | 0.87 | LAP3 (0.39) | FDPSTDP1CA4LAP3ANPEP | |
| SCHEMBL299588 | 0.87 | LAP3 (0.39) | FDPSTDP1CA4LAP3ANPEP | |
| SCHEMBL2382256 | 0.82 | CA4 (0.46) | FDPSTDP1CA4LAP3ANPEP | |
| SCHEMBL28444493 | 0.82 | CA4 (0.46) | FDPSTDP1CA4LAP3ANPEP | |
| Ammonia Solution, Strong SCHEMBL7772821 | 0.80 | CA4 (0.44) | FDPSTDP1CA4LAP3ANPEP | |
| SCHEMBL646153 | 0.78 | LAP3 (0.32) | LAP3 | |
| SCHEMBL38659685 | 0.78 | FDPS (0.35) | FDPSBLMTDP1CA4BTN3A1 | |
| SCHEMBL28734784 | 0.76 | CYP2D6 (0.37) | TDP1LAP3ANPEPERAP1 | |
| SCHEMBL19347953 | 0.76 | LAP3 (0.37) | FDPSTDP1CA4LAP3ANPEP | |
| SCHEMBL28364307 | 0.76 | LAP3 (0.37) | FDPSTDP1CA4LAP3ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160333490-A1 | Cyanide-Free Copper Preplating Electroplating Solution and Preparation Method Therefor | SUN, Songhua (CN) | 2016-11-17 | — | — | US | disclosed |
| US-20160333032-A1 | Complexing Agent and Preparation Method and Use Thereof | SUN, Songhua (CN) | 2016-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160333032-A1 | Complexing Agent and Preparation Method and Use Thereof | KCNN4, CA5A, CA2 | FDPS 2141/4885BLM 2362/4885TDP1 4315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.